ÂÜÀòÂÒÂ×

Susan Dallabrida PhD has extensive work experience in various leadership and consulting roles in the healthcare and life sciences industries.

From January 2022, Susan has been serving as the Chief Executive Officer of SPRIM PRO, a position they currently hold. Additionally, they have been the Vice President of SPRIM Consultancy since April 2020.

Susan has held advisory positions in multiple organizations. Since April 2021, they have been the Chairperson of the ObvioHealth Advisory Board. Susan has also been a Member of the Board of Directors for Pulsenmore Ltd and Travecta Therapeutics since January 2021.

Prior to their current roles, Susan worked at Oracle as a Senior Principal Clinical Consultant within the Health Sciences Global Business Unit from September 2019 to April 2020.

From May 2015 to July 2019, Susan held the position of Vice President of eCOA Clinical Science and Consulting at ERT. In this role, they led a team in eCOA/ePRO design and implementation for clinical trials and clinical care, as well as conducted instrument development and psychometric validation in accordance with regulatory guidelines.

Before joining ERT, Susan worked at PHT Corporation. From January 2014 to May 2015, they served as the Vice President of Clinical Science and Consulting, leading a team in eCOA/ePRO design and implementation. From May 2013 to December 2013, they held the role of Director of Clinical Science and Consulting, focusing on qualitative and quantitative studies for the development and validation of PRO and ePRO. From June 2012 to April 2013, Susan served as a Senior Scientific Advisor, providing scientific guidance and consultation.

Susan's earlier experience includes working as a Senior Scientist at Biogen Idec from September 2010 to June 2012, where they led a pharmacology team and conducted due diligence for collaborations. Susan also worked as a Consultant at Rubin/Anders Scientific from February 2010 to October 2010, assessing patents and identifying expert witnesses for patent litigation cases.

Susan's academic background includes positions at Harvard Medical School. From January 2003 to September 2010, they were an Instructor, leading a lab and conducting translational research in vascular biology, oncology, cardiovascular, obesity, and aging studies. Prior to that, they worked as a Post-doctoral Research Fellow from September 1999 to December 2002, focusing on translational medicine in cardiovascular disease, oncology, and obesity.

Overall, Susan Dallabrida PhD brings a wealth of experience in leadership, clinical consulting, research, and scientific advisory roles in the healthcare and life sciences industries.

Susan Dallabrida PhD began their education at Bloomsburg University of Pennsylvania from 1989 to 1993, where they obtained a Bachelor of Science (BS) and a Bachelor of Arts (BA) degree. Susan focused their studies on Biology and Chemistry during this time. Following this, Susan pursued a higher degree at Pennsylvania State University College of Medicine from 1993 to 1999. Susan successfully completed their Doctorate (PhD) in Biochemistry and Molecular Biology. No information is provided regarding their education prior to attending Bloomsburg University of Pennsylvania.